Omeros Corporation (OMER) Plunge Pleases Short Sellers

A lackluster earnings report has landed Omeros Corporation (OMER) on the short-sale restricted list

May 10, 2016 at 10:46 AM
facebook twitter linkedin


Good news for Omeros Corporation (NASDAQ:OMER) short sellers -- the drug stock is bombing on a wider-than-expected quarterly loss. In addition, the company's revenue came up short of the Street's consensus estimate, though OMER expects it will "reach cash-flow positive status later this year, fully funding [its] pipeline." With the stock short-sale restricted, intraday options volume is at triple typical levels -- though still very light, on an absolute basis.

Taking a quick step back, options traders have been buying to open OMER calls over puts at a breakneck speed in recent months. The stock's 50-day call/put volume ratio across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is a top-heavy 12.46. Plus, this ratio outstrips 96% of all others from the past year, confirming a bias toward long calls over puts.

Of course, some of these call buyers could be OMER short sellers in disguise. Roughly one-quarter of the stock's float is sold short, meaning these bears may have scooped up long calls to hedge against an unforeseen upside move. Today's post-earnings plunge, however, has short sellers sitting pretty.

Specifically, Omeros Corporation (NASDAQ:OMER) has dropped 13.8% to hover near $10.83. This is more of the same for the drug stock, which has been selling off for the past month since running into resistance in the $16 neighborhood. Earlier today, the shares explored single-digit territory for the first time since March 1.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners